What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Interview Jul 19, 2024
Expanding the Alimentiv Site Network: An Interview With Peter Westerveld

The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring…

Publication May 10, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn’s disease clinical trials
Publication May 10, 2021
Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease
Publication May 10, 2021
Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease
Publication May 10, 2021
Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy
Publication May 10, 2021
Systematic Review: Gastrointestinal Ultrasound Scoring Indices for Inflammatory Bowel Disease
Publication May 10, 2021
International consensus to standardise histopathological scoring for small bowel strictures in Crohn’s disease